Intrarenal Expression of miRNAs in Patients With Hypertensive Nephrosclerosis

Background MicroRNAs (miRNAs) are non-coding, single-stranded RNA molecules that play important roles in a number of physiological and pathological processes. Previous studies showed that miRNAs targeting transcription factors ZEB1 and ZEB2 may repress epithelial–mesenchymal transition (EMT). Method...

Full description

Saved in:
Bibliographic Details
Published inAmerican journal of hypertension Vol. 23; no. 1; pp. 78 - 84
Main Authors Wang, Gang, Kwan, Bonnie Ching-Ha, Lai, Fernand Mac-Moune, Choi, Paul Cheung-Lung, Chow, Kai-Ming, Li, Philip Kam-Tao, Szeto, Cheuk-Chun
Format Journal Article
LanguageEnglish
Published Basingstoke Oxford University Press 01.01.2010
Nature Publishing Group
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Background MicroRNAs (miRNAs) are non-coding, single-stranded RNA molecules that play important roles in a number of physiological and pathological processes. Previous studies showed that miRNAs targeting transcription factors ZEB1 and ZEB2 may repress epithelial–mesenchymal transition (EMT). Methods We studied 34 consecutive patients with biopsy-proven hypertensive nephrosclerosis. Intrarenal expression of miR-200 family, miR-205, and miR-192 were determined. We also studied normal renal tissue from 20 patients with nephrectomy for kidney cancer as controls. Results The level of intrarenal of miR-200a, miR-200b, miR-141, miR-429, miR-205, and miR-192 were significantly higher in patients with hypertensive nephrosclerosis than controls. Proteinuria correlated with intrarenal expression of miR-200a (r = 0.594, P < 0.001), miR-200b (r = 0.395, P = 0.004), miR-141 (r = 0.377, P = 0.007), miR-429 (r = 0.346, P = 0.013), miR-205 (r = 0.636, P < 0.001), and miR-192 (r = 0.306, P = 0.029). Estimated glomerular filtration rate (GFR) correlated with intrarenal expression of miR-200a (r = −0.374, P = 0.007) and miR-205 (r = −0.400, P = 0.005). Intrarenal expression of ZEB1 inversely correlated with intrarenal expression of miR-429, whereas expression of ZEB2 inversely correlated with miR-200a, miR-200b, and miR-429. Conclusions The results show that intrarenal expression of miR-200a, miR-200b, miR-141, miR-429, miR-205, and miR-192 were increased in hypertensive nephrosclerosis, and the degree of upregulation correlated with disease severity. The results suggested that these miRNA species may play important roles in the pathogenesis of hypertensive nephrosclerosis.
AbstractList Background MicroRNAs (miRNAs) are non-coding, single-stranded RNA molecules that play important roles in a number of physiological and pathological processes. Previous studies showed that miRNAs targeting transcription factors ZEB1 and ZEB2 may repress epithelial-mesenchymal transition (EMT). Methods We studied 34 consecutive patients with biopsy-proven hypertensive nephrosclerosis. Intrarenal expression of miR-200 family, miR-205, and miR-192 were determined. We also studied normal renal tissue from 20 patients with nephrectomy for kidney cancer as controls. Results The level of intrarenal of miR-200a, miR-200b, miR-141, miR-429, miR-205, and miR-192 were significantly higher in patients with hypertensive nephrosclerosis than controls. Proteinuria correlated with intrarenal expression of miR-200a (r = 0.594, P < 0.001), miR-200b (r = 0.395, P = 0.004), miR-141 (r = 0.377, P = 0.007), miR-429 (r = 0.346, P = 0.013), miR-205 (r = 0.636, P < 0.001), and miR-192 (r = 0.306, P = 0.029). Estimated glomerular filtration rate (GFR) correlated with intrarenal expression of miR-200a (r = −0.374, P = 0.007) and miR-205 (r = −0.400, P = 0.005). Intrarenal expression of ZEB1 inversely correlated with intrarenal expression of miR-429, whereas expression of ZEB2 inversely correlated with miR-200a, miR-200b, and miR-429. Conclusions The results show that intrarenal expression of miR-200a, miR-200b, miR-141, miR-429, miR-205, and miR-192 were increased in hypertensive nephrosclerosis, and the degree of upregulation correlated with disease severity. The results suggested that these miRNA species may play important roles in the pathogenesis of hypertensive nephrosclerosis.
Background MicroRNAs (miRNAs) are non-coding, single-stranded RNA molecules that play important roles in a number of physiological and pathological processes. Previous studies showed that miRNAs targeting transcription factors ZEB1 and ZEB2 may repress epithelial–mesenchymal transition (EMT). Methods We studied 34 consecutive patients with biopsy-proven hypertensive nephrosclerosis. Intrarenal expression of miR-200 family, miR-205, and miR-192 were determined. We also studied normal renal tissue from 20 patients with nephrectomy for kidney cancer as controls. Results The level of intrarenal of miR-200a, miR-200b, miR-141, miR-429, miR-205, and miR-192 were significantly higher in patients with hypertensive nephrosclerosis than controls. Proteinuria correlated with intrarenal expression of miR-200a (r = 0.594, P < 0.001), miR-200b (r = 0.395, P = 0.004), miR-141 (r = 0.377, P = 0.007), miR-429 (r = 0.346, P = 0.013), miR-205 (r = 0.636, P < 0.001), and miR-192 (r = 0.306, P = 0.029). Estimated glomerular filtration rate (GFR) correlated with intrarenal expression of miR-200a (r = −0.374, P = 0.007) and miR-205 (r = −0.400, P = 0.005). Intrarenal expression of ZEB1 inversely correlated with intrarenal expression of miR-429, whereas expression of ZEB2 inversely correlated with miR-200a, miR-200b, and miR-429. Conclusions The results show that intrarenal expression of miR-200a, miR-200b, miR-141, miR-429, miR-205, and miR-192 were increased in hypertensive nephrosclerosis, and the degree of upregulation correlated with disease severity. The results suggested that these miRNA species may play important roles in the pathogenesis of hypertensive nephrosclerosis.
MicroRNAs (miRNAs) are non-coding, single-stranded RNA molecules that play important roles in a number of physiological and pathological processes. Previous studies showed that miRNAs targeting transcription factors ZEB1 and ZEB2 may repress epithelial-mesenchymal transition (EMT). We studied 34 consecutive patients with biopsy-proven hypertensive nephrosclerosis. Intrarenal expression of miR-200 family, miR-205, and miR-192 were determined. We also studied normal renal tissue from 20 patients with nephrectomy for kidney cancer as controls. The level of intrarenal of miR-200a, miR-200b, miR-141, miR-429, miR-205, and miR-192 were significantly higher in patients with hypertensive nephrosclerosis than controls. Proteinuria correlated with intrarenal expression of miR-200a (r = 0.594, P < 0.001), miR-200b (r = 0.395, P = 0.004), miR-141 (r = 0.377, P = 0.007), miR-429 (r = 0.346, P = 0.013), miR-205 (r = 0.636, P < 0.001), and miR-192 (r = 0.306, P = 0.029). Estimated glomerular filtration rate (GFR) correlated with intrarenal expression of miR-200a (r = -0.374, P = 0.007) and miR-205 (r = -0.400, P = 0.005). Intrarenal expression of ZEB1 inversely correlated with intrarenal expression of miR-429, whereas expression of ZEB2 inversely correlated with miR-200a, miR-200b, and miR-429. The results show that intrarenal expression of miR-200a, miR-200b, miR-141, miR-429, miR-205, and miR-192 were increased in hypertensive nephrosclerosis, and the degree of upregulation correlated with disease severity. The results suggested that these miRNA species may play important roles in the pathogenesis of hypertensive nephrosclerosis.
MicroRNAs (miRNAs) are non-coding, single-stranded RNA molecules that play important roles in a number of physiological and pathological processes. Previous studies showed that miRNAs targeting transcription factors ZEB1 and ZEB2 may repress epithelial-mesenchymal transition (EMT). We studied 34 consecutive patients with biopsy-proven hypertensive nephrosclerosis. Intrarenal expression of miR-200 family, miR-205, and miR-192 were determined. We also studied normal renal tissue from 20 patients with nephrectomy for kidney cancer as controls. The level of intrarenal of miR-200a, miR-200b, miR-141, miR-429, miR-205, and miR-192 were significantly higher in patients with hypertensive nephrosclerosis than controls. Proteinuria correlated with intrarenal expression of miR-200a (r = 0.594, P < 0.001), miR-200b (r = 0.395, P = 0.004), miR-141 (r = 0.377, P = 0.007), miR-429 (r = 0.346, P = 0.013), miR-205 (r = 0.636, P < 0.001), and miR-192 (r = 0.306, P = 0.029). Estimated glomerular filtration rate (GFR) correlated with intrarenal expression of miR-200a (r = -0.374, P = 0.007) and miR-205 (r = -0.400, P = 0.005). Intrarenal expression of ZEB1 inversely correlated with intrarenal expression of miR-429, whereas expression of ZEB2 inversely correlated with miR-200a, miR-200b, and miR-429. The results show that intrarenal expression of miR-200a, miR-200b, miR-141, miR-429, miR-205, and miR-192 were increased in hypertensive nephrosclerosis, and the degree of upregulation correlated with disease severity. The results suggested that these miRNA species may play important roles in the pathogenesis of hypertensive nephrosclerosis.
MicroRNAs (miRNAs) are non-coding, single-stranded RNA molecules that play important roles in a number of physiological and pathological processes. Previous studies showed that miRNAs targeting transcription factors ZEB1 and ZEB2 may repress epithelial-mesenchymal transition (EMT).BACKGROUNDMicroRNAs (miRNAs) are non-coding, single-stranded RNA molecules that play important roles in a number of physiological and pathological processes. Previous studies showed that miRNAs targeting transcription factors ZEB1 and ZEB2 may repress epithelial-mesenchymal transition (EMT).We studied 34 consecutive patients with biopsy-proven hypertensive nephrosclerosis. Intrarenal expression of miR-200 family, miR-205, and miR-192 were determined. We also studied normal renal tissue from 20 patients with nephrectomy for kidney cancer as controls.METHODSWe studied 34 consecutive patients with biopsy-proven hypertensive nephrosclerosis. Intrarenal expression of miR-200 family, miR-205, and miR-192 were determined. We also studied normal renal tissue from 20 patients with nephrectomy for kidney cancer as controls.The level of intrarenal of miR-200a, miR-200b, miR-141, miR-429, miR-205, and miR-192 were significantly higher in patients with hypertensive nephrosclerosis than controls. Proteinuria correlated with intrarenal expression of miR-200a (r = 0.594, P < 0.001), miR-200b (r = 0.395, P = 0.004), miR-141 (r = 0.377, P = 0.007), miR-429 (r = 0.346, P = 0.013), miR-205 (r = 0.636, P < 0.001), and miR-192 (r = 0.306, P = 0.029). Estimated glomerular filtration rate (GFR) correlated with intrarenal expression of miR-200a (r = -0.374, P = 0.007) and miR-205 (r = -0.400, P = 0.005). Intrarenal expression of ZEB1 inversely correlated with intrarenal expression of miR-429, whereas expression of ZEB2 inversely correlated with miR-200a, miR-200b, and miR-429.RESULTSThe level of intrarenal of miR-200a, miR-200b, miR-141, miR-429, miR-205, and miR-192 were significantly higher in patients with hypertensive nephrosclerosis than controls. Proteinuria correlated with intrarenal expression of miR-200a (r = 0.594, P < 0.001), miR-200b (r = 0.395, P = 0.004), miR-141 (r = 0.377, P = 0.007), miR-429 (r = 0.346, P = 0.013), miR-205 (r = 0.636, P < 0.001), and miR-192 (r = 0.306, P = 0.029). Estimated glomerular filtration rate (GFR) correlated with intrarenal expression of miR-200a (r = -0.374, P = 0.007) and miR-205 (r = -0.400, P = 0.005). Intrarenal expression of ZEB1 inversely correlated with intrarenal expression of miR-429, whereas expression of ZEB2 inversely correlated with miR-200a, miR-200b, and miR-429.The results show that intrarenal expression of miR-200a, miR-200b, miR-141, miR-429, miR-205, and miR-192 were increased in hypertensive nephrosclerosis, and the degree of upregulation correlated with disease severity. The results suggested that these miRNA species may play important roles in the pathogenesis of hypertensive nephrosclerosis.CONCLUSIONSThe results show that intrarenal expression of miR-200a, miR-200b, miR-141, miR-429, miR-205, and miR-192 were increased in hypertensive nephrosclerosis, and the degree of upregulation correlated with disease severity. The results suggested that these miRNA species may play important roles in the pathogenesis of hypertensive nephrosclerosis.
Author Choi, Paul Cheung-Lung
Kwan, Bonnie Ching-Ha
Lai, Fernand Mac-Moune
Chow, Kai-Ming
Szeto, Cheuk-Chun
Wang, Gang
Li, Philip Kam-Tao
Author_xml – sequence: 1
  givenname: Gang
  surname: Wang
  fullname: Wang, Gang
  email: ccszeto@cuhk.edu.hk
  organization: Department of Medicine and Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong, Sha Tin, Hong Kong
– sequence: 2
  givenname: Bonnie Ching-Ha
  surname: Kwan
  fullname: Kwan, Bonnie Ching-Ha
  organization: Department of Medicine and Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong, Sha Tin, Hong Kong
– sequence: 3
  givenname: Fernand Mac-Moune
  surname: Lai
  fullname: Lai, Fernand Mac-Moune
  organization: Department of Anatomical and Cellular Pathology, Prince of Wales Hospital, The Chinese University of Hong Kong, Sha Tin, Hong Kong
– sequence: 4
  givenname: Paul Cheung-Lung
  surname: Choi
  fullname: Choi, Paul Cheung-Lung
  organization: Department of Anatomical and Cellular Pathology, Prince of Wales Hospital, The Chinese University of Hong Kong, Sha Tin, Hong Kong
– sequence: 5
  givenname: Kai-Ming
  surname: Chow
  fullname: Chow, Kai-Ming
  organization: Department of Medicine and Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong, Sha Tin, Hong Kong
– sequence: 6
  givenname: Philip Kam-Tao
  surname: Li
  fullname: Li, Philip Kam-Tao
  organization: Department of Medicine and Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong, Sha Tin, Hong Kong
– sequence: 7
  givenname: Cheuk-Chun
  surname: Szeto
  fullname: Szeto, Cheuk-Chun
  organization: Department of Medicine and Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong, Sha Tin, Hong Kong
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=22493310$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/19910931$$D View this record in MEDLINE/PubMed
BookMark eNqFkU1vEzEQhi1URNPAjTNaCSEubPHnevdYqkIqlYIiEIiLNfHOKg4be7F3UfvvcZSQQ4XE5fXlGY_mec_IiQ8eCXnO6Dmjon4Lm_U5p7TJUT8iM9ZIVmrO1QmZ0bpRpaYVOyVnKW0opbKq2BNyypqG0UawGfl47ccIET30xdXdEDElF3wRumLrlrcXqXC--AyjQz-m4psb18XifsA4ok_uNxa3OKxjSLbHnC49JY876BM-O7xz8vX91ZfLRXnz6cP15cVNaaWqxpIhyhpb1bZQdaIGQAUrlLhi2ALVUlnKlO46yzmvK6ZXFUgAoTsLmknRiTl5vf93iOHXhGk0W5cs9j14DFMyWgjdqFqJTL58QG7CFPO1yTDKpWpy7KgXB2pabbE1Q3RbiPfmr6cMvDoAkCz0XQRvXTpynMtGiFzHnPA9Z7OPFLEz1o1ZX9hZdn3eaXalmVya2ZWWo85Dbx4MHff_Gz8cH6bhf2S5J10a8e7IQvxpKi20MovvP8xywd5VSyGztD_T3LNB
CODEN AJHYE6
CitedBy_id crossref_primary_10_3389_fphar_2020_563756
crossref_primary_10_1111_eci_12420
crossref_primary_10_1111_eci_12585
crossref_primary_10_1007_s00441_011_1227_1
crossref_primary_10_3390_biom11121771
crossref_primary_10_1007_s00467_013_2434_7
crossref_primary_10_1161_HYPERTENSIONAHA_118_11875
crossref_primary_10_1016_j_semnephrol_2013_05_008
crossref_primary_10_1371_journal_pone_0063390
crossref_primary_10_1152_ajprenal_00387_2015
crossref_primary_10_1681_ASN_2010020134
crossref_primary_10_3390_ijms21093107
crossref_primary_10_1016_j_yexcr_2013_04_011
crossref_primary_10_1038_ki_2011_43
crossref_primary_10_1016_j_tice_2017_01_003
crossref_primary_10_1038_ki_2011_448
crossref_primary_10_1152_physrev_00045_2011
crossref_primary_10_3892_ijmm_2013_1554
crossref_primary_10_1016_j_abb_2018_06_013
crossref_primary_10_3892_mmr_2018_8839
crossref_primary_10_1155_2015_107814
crossref_primary_10_1016_j_semnephrol_2012_04_004
crossref_primary_10_2337_db16_1031
crossref_primary_10_1016_j_yexcr_2019_111778
crossref_primary_10_1152_ajprenal_00266_2016
crossref_primary_10_1155_2015_682857
crossref_primary_10_1186_2046_2395_1_10
crossref_primary_10_1007_s11906_011_0235_6
crossref_primary_10_1016_j_kint_2021_02_024
crossref_primary_10_1016_j_urology_2017_07_020
crossref_primary_10_1016_j_mehy_2013_04_031
crossref_primary_10_3390_antiox13080958
crossref_primary_10_3892_etm_2015_2468
crossref_primary_10_1186_s12882_019_1512_x
crossref_primary_10_1016_j_kint_2020_02_008
crossref_primary_10_1097_TP_0b013e3182751efd
crossref_primary_10_1016_j_pharmthera_2024_108709
crossref_primary_10_1016_j_trre_2017_12_001
crossref_primary_10_1161_CIRCULATIONAHA_111_072108
crossref_primary_10_1038_s41371_020_0338_0
crossref_primary_10_1074_jbc_M113_453043
crossref_primary_10_3390_app11167674
crossref_primary_10_1016_j_tig_2012_04_001
crossref_primary_10_1517_17425255_2014_967681
crossref_primary_10_1186_s12967_018_1604_6
crossref_primary_10_1002_iub_1174
crossref_primary_10_1038_pr_2016_121
crossref_primary_10_1186_s12882_016_0366_8
crossref_primary_10_3389_fmed_2022_849075
crossref_primary_10_1042_BJ20111861
crossref_primary_10_1126_scisignal_2003389
crossref_primary_10_1016_j_yexmp_2012_10_011
crossref_primary_10_1016_j_isci_2021_102928
crossref_primary_10_1093_nar_gkr232
crossref_primary_10_1093_ndt_gft223
crossref_primary_10_1152_ajpcell_00219_2018
crossref_primary_10_1016_j_bbrc_2017_01_145
crossref_primary_10_1134_S0026893322010034
crossref_primary_10_1111_1440_1681_13213
crossref_primary_10_1053_j_ajkd_2016_01_027
crossref_primary_10_1080_20013078_2017_1314073
crossref_primary_10_1186_s12899_015_0016_6
crossref_primary_10_1016_j_cca_2012_12_011
crossref_primary_10_1586_erm_12_131
crossref_primary_10_2174_0113816128266582231031111516
crossref_primary_10_1111_j_1440_1797_2010_01363_x
crossref_primary_10_1371_journal_pone_0030771
crossref_primary_10_1371_journal_pone_0054662
crossref_primary_10_1002_jcp_27822
crossref_primary_10_1074_jbc_M110_208066
crossref_primary_10_1152_ajprenal_00727_2010
crossref_primary_10_1681_ASN_2011050485
crossref_primary_10_1681_ASN_2012080849
crossref_primary_10_1053_j_ajkd_2012_09_018
crossref_primary_10_2337_db13_0305
crossref_primary_10_1016_j_coph_2016_02_001
crossref_primary_10_1177_1933719113488453
crossref_primary_10_1016_j_yexcr_2012_02_034
crossref_primary_10_1177_0961203310389841
crossref_primary_10_1016_j_trsl_2012_01_020
crossref_primary_10_1161_HYPERTENSIONAHA_111_187104
crossref_primary_10_1042_BST20120085
crossref_primary_10_2174_1871530319666190301154640
crossref_primary_10_1007_s10157_013_0906_5
crossref_primary_10_1038_nrneph_2011_26
crossref_primary_10_3390_ijms19061797
crossref_primary_10_1016_j_fct_2016_02_018
crossref_primary_10_2337_db09_1736
crossref_primary_10_1042_CS20110159
Cites_doi 10.1681/ASN.2008030312
10.1038/ncpneph0093
10.1369/jhc.2008.950998
10.1007/s00296-008-0758-6
10.7326/0003-4819-130-6-199903160-00002
10.1186/1471-2164-9-624
10.4161/cc.7.20.6851
10.1073/pnas.0611192104
10.1016/j.trim.2008.01.007
10.1096/fj.08-112326
10.1016/j.devcel.2006.09.009
10.1158/0008-5472.CAN-08-1942
10.1097/MNH.0b013e3282f88a1f
10.1681/ASN.2008020162
10.1126/science.1152623
10.1016/0272-6386(95)90001-2
10.1242/dev.02073
10.1100/tsw.2008.115
10.1038/nrneph.2009.74
10.1126/science.1149460
10.1056/NEJMoa051907
10.1093/ndt/14.10.2271
ContentType Journal Article
Copyright American Journal of Hypertension, Ltd. © 2010 by the American Journal of Hypertension, Ltd. 2010
2015 INIST-CNRS
Copyright Nature Publishing Group Jan 2010
Copyright_xml – notice: American Journal of Hypertension, Ltd. © 2010 by the American Journal of Hypertension, Ltd. 2010
– notice: 2015 INIST-CNRS
– notice: Copyright Nature Publishing Group Jan 2010
DBID BSCLL
AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7X7
7XB
88E
8FI
8FJ
8FK
ABUWG
AFKRA
BENPR
CCPQU
FYUFA
GHDGH
K9.
M0S
M1P
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
7X8
DOI 10.1038/ajh.2009.208
DatabaseName Istex
CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central
ProQuest One Community College
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
ProQuest Health & Medical Collection
Medical Database
ProQuest Central Premium
ProQuest One Academic (New)
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest One Academic Middle East (New)
ProQuest One Academic Eastern Edition
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
ProQuest Central
ProQuest Health & Medical Complete
ProQuest Health & Medical Research Collection
Health Research Premium Collection
ProQuest Medical Library
ProQuest One Academic UKI Edition
Health and Medicine Complete (Alumni Edition)
Health & Medical Research Collection
ProQuest Central (New)
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Medical Library (Alumni)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList

MEDLINE
ProQuest One Academic Middle East (New)
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: 7X7
  name: Health & Medical Collection
  url: https://search.proquest.com/healthcomplete
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1941-7225
EndPage 84
ExternalDocumentID 2708887301
19910931
22493310
10_1038_ajh_2009_208
10.1038/ajh.2009.208
ark_67375_HXZ_RH1B6R34_7
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
--K
.2P
.55
.GJ
.I3
.ZR
0R~
1B1
1TH
1~5
23M
39C
4.4
48X
4G.
53G
5GY
5RE
5VS
5WD
7-5
70F
7X7
88E
8FI
8FJ
AABZA
AACZT
AAEDT
AAFWJ
AAJKP
AAJQQ
AALRI
AAMVS
AAOGV
AAPGJ
AAPQZ
AAPXW
AAQXK
AARHZ
AAUAY
AAUQX
AAVAP
AAWDT
AAXUO
ABDFA
ABEJV
ABEUO
ABGNP
ABIXL
ABJNI
ABKDP
ABMAC
ABNGD
ABNHQ
ABNKS
ABOCM
ABPQP
ABPTD
ABQLI
ABQNK
ABSMQ
ABUWG
ABVGC
ABWST
ABWVN
ABXVV
ABZBJ
ACFRR
ACGFS
ACIUM
ACRPL
ACUFI
ACUKT
ACUTJ
ACUTO
ACVCV
ACVFH
ACYHN
ACZBC
ADBBV
ADCNI
ADEYI
ADGZP
ADHKW
ADHZD
ADIPN
ADMTO
ADMUD
ADNBA
ADNMO
ADOCK
ADQBN
ADRTK
ADVEK
ADYVW
ADZXQ
AEGPL
AEJOX
AEKSI
AEMDU
AEMQT
AENEX
AENZO
AEPUE
AETBJ
AEUPX
AEWNT
AFFNX
AFFQV
AFFZL
AFIYH
AFKRA
AFOFC
AFPUW
AFXAL
AFYAG
AGINJ
AGKRT
AGMDO
AGORE
AGQPQ
AGQXC
AGSYK
AGUTN
AHGBF
AHMBA
AHMMS
AHXPO
AIGII
AITUG
AJBYB
AJDVS
AJEEA
AJNCP
AKRWK
ALIPV
ALMA_UNASSIGNED_HOLDINGS
ALUQC
ALXQX
APIBT
APJGH
AQDSO
AQKUS
ASPBG
ATGXG
AVNTJ
AVWKF
AXUDD
AZFZN
BAYMD
BCRHZ
BENPR
BEYMZ
BHONS
BPHCQ
BSCLL
BTRTY
BVRKM
BVXVI
BZKNY
C45
CAG
CCPQU
CDBKE
COF
CS3
DAKXR
DILTD
D~K
EBS
EE~
EIHJH
EJD
EMOBN
ENERS
EO8
F5P
F9B
FDB
FECEO
FEDTE
FGOYB
FLUFQ
FOEOM
FOTVD
FQBLK
FYUFA
G-Q
GAUVT
GJXCC
H13
H5~
HAR
HMCUK
HVGLF
HW0
HZ~
IHE
J21
JSO
JXSIZ
KBUDW
KOP
KSI
KSN
M1P
M41
MBLQV
MHKGH
ML0
NGC
NOMLY
NOYVH
NQ-
NU-
NVLIB
O0~
O9-
OAUYM
OAWHX
OBFPC
OCZFY
ODMLO
OJQWA
OJZSN
OPAEJ
OVD
OWPYF
O~Y
P2P
PAFKI
PB-
PEELM
PHGZM
PHGZT
PJZUB
PPXIY
PQQKQ
PROAC
PSQYO
Q1.
Q5Y
R2-
RIG
ROL
ROX
ROZ
RPZ
RUSNO
RW1
RXO
SDP
SSZ
TEORI
TJX
TMA
UKHRP
WH7
X7M
XPP
YAYTL
YKOAZ
YXANX
YYP
ZGI
ZXP
3V.
AASNB
AAYOK
ABSAR
ADJQC
ADRIX
AFXEN
AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7XB
8FK
K9.
PKEHL
PQEST
PQUKI
7X8
ID FETCH-LOGICAL-c456t-1ee48ed5dda6f38aae5abe4eb1eda0745c0157ffc2228617b6a4aa37fca7143f3
IEDL.DBID 7X7
ISSN 0895-7061
1941-7225
IngestDate Fri Jul 11 07:34:28 EDT 2025
Sat Aug 23 13:31:04 EDT 2025
Mon Jul 21 05:57:53 EDT 2025
Mon Jul 21 09:15:09 EDT 2025
Thu Apr 24 23:11:36 EDT 2025
Tue Jul 01 01:20:30 EDT 2025
Wed Aug 28 03:22:53 EDT 2024
Tue Aug 05 16:48:39 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords blood pressure
microRNA
hypertension
renal disease
Human
Hypertension
Kidney disease
Urinary system disease
Cardiovascular disease
Arterial pressure
Blood pressure
Intrarenal
Language English
License CC BY 4.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c456t-1ee48ed5dda6f38aae5abe4eb1eda0745c0157ffc2228617b6a4aa37fca7143f3
Notes ark:/67375/HXZ-RH1B6R34-7
istex:5759B190FA8F180DCFA092CC2432005953481F3A
href:23_1_78.pdf
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
OpenAccessLink https://academic.oup.com/ajh/article-pdf/23/1/78/351053/23_1_78.pdf
PMID 19910931
PQID 1024590243
PQPubID 536305
PageCount 7
ParticipantIDs proquest_miscellaneous_733795853
proquest_journals_1024590243
pubmed_primary_19910931
pascalfrancis_primary_22493310
crossref_citationtrail_10_1038_ajh_2009_208
crossref_primary_10_1038_ajh_2009_208
oup_primary_10_1038_ajh_2009_208
istex_primary_ark_67375_HXZ_RH1B6R34_7
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2010-01
20100100
2010-01-01
2010
2010-Jan
20100101
PublicationDateYYYYMMDD 2010-01-01
PublicationDate_xml – month: 01
  year: 2010
  text: 2010-01
PublicationDecade 2010
PublicationPlace Basingstoke
PublicationPlace_xml – name: Basingstoke
– name: United States
– name: Oxford
PublicationTitle American journal of hypertension
PublicationTitleAlternate AJH
PublicationYear 2010
Publisher Oxford University Press
Nature Publishing Group
Publisher_xml – name: Oxford University Press
– name: Nature Publishing Group
References (24_31856900) 2008; 19
Levey (14_10742031) 1999; 130
Bhandari (16_38516817) 2008; 56
Alvarez-Garcia (8_19468205) 2005; 132
Pandey (19_33395281) 2008; 9
Sui (22_30668326) 2008; 19
Marcantoni (5_29567913) 2007; 20
(11_38901620) 2008; 8
Luke (3_11001704) 1999; 14
Neilson (13_22545557) 2006; 2
(23_32055876) 2008; 19
(12_23669116) 2007; 104
Bracken (10_32029174) 2008; 68
Dai (21_32364267) 2008; 29
Grande (26_34955139) 2009; 5
(28_29927658) 2007; 318
Hill (4_30903872) 2008; 17
(25_31747147) 2008; 22
Buchan (27_30104778) 2007; 318
Freedman (6_15757965) 1995; 25
Muthukumar (18_19692014) 2005; 353
Kloosterman (7_22756710) 2006; 11
Gregory (9_32277657) 2008; 7
Dai (20_32595547) 2009; 29
References_xml – volume: 19
  start-page: 2159
  issn: 1046-6673
  issue: 11
  year: 2008
  ident: 24_31856900
  publication-title: Journal of the American Society of Nephrology
  doi: 10.1681/ASN.2008030312
– volume: 2
  start-page: 101
  issn: 1745-8323
  issue: 2
  year: 2006
  ident: 13_22545557
  doi: 10.1038/ncpneph0093
– volume: 56
  start-page: 733
  issn: 0022-1554
  issue: 8
  year: 2008
  ident: 16_38516817
  publication-title: Journal of Histochemistry & Cytochemistry
  doi: 10.1369/jhc.2008.950998
– volume: 29
  start-page: 749
  issn: 0172-8172
  issue: 7
  year: 2009
  ident: 20_32595547
  publication-title: Rheumatology international
  doi: 10.1007/s00296-008-0758-6
– volume: 130
  start-page: 461
  issn: 0003-4819
  issue: 6
  year: 1999
  ident: 14_10742031
  publication-title: Annals of Internal Medicine
  doi: 10.7326/0003-4819-130-6-199903160-00002
– volume: 9
  start-page: 624
  issn: 1471-2164
  year: 2008
  ident: 19_33395281
  publication-title: BMC genomics [electronic resource]
  doi: 10.1186/1471-2164-9-624
– volume: 7
  start-page: 3112
  issn: 1538-4101
  issue: 20
  year: 2008
  ident: 9_32277657
  publication-title: Cell cycle (Georgetown, Tex.)
  doi: 10.4161/cc.7.20.6851
– volume: 104
  start-page: 3432
  issn: 0027-8424
  issue: 9
  year: 2007
  ident: 12_23669116
  publication-title: PNAS
  doi: 10.1073/pnas.0611192104
– volume: 19
  start-page: 81
  issn: 0966-3274
  issue: 1
  year: 2008
  ident: 22_30668326
  publication-title: Transplant immunology
  doi: 10.1016/j.trim.2008.01.007
– volume: 22
  start-page: 4126
  issn: 0892-6638
  issue: 12
  year: 2008
  ident: 25_31747147
  publication-title: The FASEB Journal
  doi: 10.1096/fj.08-112326
– volume: 11
  start-page: 441
  issn: 1534-5807
  issue: 4
  year: 2006
  ident: 7_22756710
  publication-title: Developmental cell
  doi: 10.1016/j.devcel.2006.09.009
– volume: 29
  start-page: 1388
  issn: 0379-5284
  issue: 10
  year: 2008
  ident: 21_32364267
  publication-title: Saudi medical journal
– volume: 20
  start-page: 518
  issn: 1121-8428
  issue: 5
  year: 2007
  ident: 5_29567913
  publication-title: Journal of nephrology
– volume: 68
  start-page: 7846
  issn: 0008-5472
  issue: 19
  year: 2008
  ident: 10_32029174
  publication-title: Cancer Research
  doi: 10.1158/0008-5472.CAN-08-1942
– volume: 17
  start-page: 266
  issn: 1062-4821
  issue: 3
  year: 2008
  ident: 4_30903872
  publication-title: Current opinion in nephrology and hypertension
  doi: 10.1097/MNH.0b013e3282f88a1f
– volume: 19
  start-page: 2069
  issn: 1046-6673
  issue: 11
  year: 2008
  ident: 23_32055876
  publication-title: Journal of the American Society of Nephrology
  doi: 10.1681/ASN.2008020162
– volume: 318
  start-page: 1877
  issn: 0036-8075
  issue: 5858
  year: 2007
  ident: 27_30104778
  publication-title: Science
  doi: 10.1126/science.1152623
– volume: 25
  start-page: 207
  issn: 0272-6386
  issue: 2
  year: 1995
  ident: 6_15757965
  publication-title: American journal of kidney diseases : the official journal of the National Kidney Foundation
  doi: 10.1016/0272-6386(95)90001-2
– volume: 132
  start-page: 4653
  issn: 0950-1991
  issue: 21
  year: 2005
  ident: 8_19468205
  publication-title: Development
  doi: 10.1242/dev.02073
– volume: 8
  start-page: 901
  issn: 1537-744X
  year: 2008
  ident: 11_38901620
  publication-title: TheScientificWorldJournal [electronic resource]
  doi: 10.1100/tsw.2008.115
– volume: 5
  start-page: 319
  issn: 1759-507X
  issue: 6
  year: 2009
  ident: 26_34955139
  doi: 10.1038/nrneph.2009.74
– volume: 318
  start-page: 1931
  issn: 0036-8075
  issue: 5858
  year: 2007
  ident: 28_29927658
  publication-title: Science
  doi: 10.1126/science.1149460
– volume: 353
  start-page: 2342
  issn: 0028-4793
  issue: 22
  year: 2005
  ident: 18_19692014
  publication-title: New England Journal of Medicine
  doi: 10.1056/NEJMoa051907
– volume: 14
  start-page: 2271
  issn: 0931-0509
  issue: 10
  year: 1999
  ident: 3_11001704
  publication-title: Nephrology Dialysis Transplantation
  doi: 10.1093/ndt/14.10.2271
SSID ssj0004661
Score 2.3099492
Snippet Background MicroRNAs (miRNAs) are non-coding, single-stranded RNA molecules that play important roles in a number of physiological and pathological processes....
Background MicroRNAs (miRNAs) are non-coding, single-stranded RNA molecules that play important roles in a number of physiological and pathological processes....
MicroRNAs (miRNAs) are non-coding, single-stranded RNA molecules that play important roles in a number of physiological and pathological processes. Previous...
SourceID proquest
pubmed
pascalfrancis
crossref
oup
istex
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 78
SubjectTerms Adult
Aged
Antihypertensive agents
Arterial hypertension. Arterial hypotension
Biological and medical sciences
Blood and lymphatic vessels
Blood Pressure
Cardiology. Vascular system
Cardiovascular system
Female
Glomerular Filtration Rate
Homeodomain Proteins - metabolism
Humans
hypertension
Hypertension - complications
Hypertension - physiopathology
Kidney - metabolism
Male
Medical sciences
microRNA
MicroRNAs - metabolism
Middle Aged
Nephrosclerosis - etiology
Nephrosclerosis - genetics
Nephrosclerosis - physiopathology
Pharmacology. Drug treatments
renal disease
Repressor Proteins - metabolism
Severity of Illness Index
Transcription Factors - metabolism
Up-Regulation
Zinc Finger E-box Binding Homeobox 2
Zinc Finger E-box-Binding Homeobox 1
Title Intrarenal Expression of miRNAs in Patients With Hypertensive Nephrosclerosis
URI https://api.istex.fr/ark:/67375/HXZ-RH1B6R34-7/fulltext.pdf
https://www.ncbi.nlm.nih.gov/pubmed/19910931
https://www.proquest.com/docview/1024590243
https://www.proquest.com/docview/733795853
Volume 23
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV3fa9swED62BspgjK1dt2xd0MPal2HqWFJkP412pHiDhBJaFvYiZFmi2Q87i1Pon787W0m7h24vfvEhG93p9OnudB_Ae1d6ZZPCRjIr8YBiuIhS7-II5UvDTYJ7LoUGJtNRfiW-zOU8BNyaUFa58Ymtoy5rSzFyXN2JoFYjgn9c_o6INYqyq4FC4zH0qHUZlXSpubp3L7LtlxqnmYwUblyh8D3m6Yn5ft01q0yIWPLeltSj2b3dXHd7ujQNzpXvSC4eRqHtbnT-HJ4FGMlOO72_gEeu2oPdSUiU78Pkc3uf3pHQ-DYUu1as9uzXYjY9bdiiYhddS9WGfV2sr1mOB9JVKGdnU4c6rhscGp-L5iVcnY8vP-VRYE6ILAKidTR0TqSulGVpRp6nxjhpCifQL6MGEDRIiyhAeW8p_oMYphgZYQxX3hriQ_f8AHaqunKvgSEeKLhEd6pcIhzPTBanyhfK2rIgNr8-fNhMnrahrTixW_zUbXqbpxqnmsguM3ykfTjaSi-7dhoPyB23etgKmdUPKkFTUufzb3qWD89GMy606gNDRf1nrMFfWtwKI3rJOMLbPhxu1KrDCm70nb3hJ7avce1RQsVUrr5ptOJcodVJFHnVWcPdjyDujjM-fPPvsd_Ck64cgWI6h7CzXt24d4hy1sWgNeUB9M7G04vZHx0d-tk
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB6VXQmQECrvhbb4QLmgiGzsrJMDQn1slaXdqFq1YsXFOI6tLo9k2WxF-VP8RsaJsy2HwqkXXzJyLM94Hp7xfACvdG64CjLlhXGOAYqkzIuM9j2kzyWVAdpcezUwTgfJKfswDadr8Lt9C2PLKludWCvqvFT2jhxPd8BsqxFG389_eBY1ymZXWwiNRiwO9a-fGLJV70b7yN_tIDgYnuwlnkMV8BQ6C0uvrzWLdB7muRwYGkmpQ5lphjoLV4cGNVRoIbkxyt6NoH3PBpJJSblR0mKFG4rz3oIuoxjKdKC7O0yPJ1deYtYdWv0oDj2OptKV2vs0eiu_nDXtMQMLZXnFCHYtPy_aB3b35rJC7pgGVuN6v7e2fwfrcN85rmSnkbQHsKaLh3B77FLzj2A8ql_wa0s0vHDltQUpDfk-m6Q7FZkV5Lhp4lqRj7PlGUkwBF64AnqSapSqssKpcZxVj-H0Rnb1CXSKstDPgKAHktEQFTjXAdM0lrEfcZNxpfLM4gf24E27eUK5RuYWT-ObqBPqNBK41RZeM8Yh6sH2inreNPC4hu51zYcVkVx8tUVvPBTJ9JOYJP3dwYQywXtAkFH_mWvrLy6uiNFfiik61D3YaNkqnM6oxKWE4y9Wn_G02xSOLHR5XglOKY8xwkOSp400XC4EPX0_pv3n_577JdxJTsZH4miUHr6Au00xhL1R2oDOcnGuN9HHWmZbTrAJfL7ps_QHZ-k50w
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Intrarenal+Expression+of+miRNAs+in+Patients+With+Hypertensive+Nephrosclerosis&rft.jtitle=American+journal+of+hypertension&rft.au=GANG+WANG&rft.au=KWAN%2C+Bonnie+Ching-Ha&rft.au=LAI%2C+Fernand+Mac-Moune&rft.au=CHOI%2C+Paul+Cheung-Lung&rft.date=2010&rft.pub=Nature+Publishing+Group&rft.issn=0895-7061&rft.volume=23&rft.issue=1&rft.spage=78&rft.epage=84&rft_id=info:doi/10.1038%2Fajh.2009.208&rft.externalDBID=n%2Fa&rft.externalDocID=22493310
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0895-7061&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0895-7061&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0895-7061&client=summon